JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Incidences, Trends and Long Term Outcomes of Retinoblastoma in Three Cancer Registries, Thailand
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Incidences, Trends and Long Term Outcomes of Retinoblastoma in Three Cancer Registries, Thailand
Wongmas, Piyathida; Jetsrisuparb, Arunee; Komvilaisak, Patcharee; Suwanrungruang, Krittika; Choeyprasert, Worawut; Sriplung, Hutcha; Wiangnon, Surapon;
  PDF(new window)
 Abstract
Background: Retinoblastoma (RB) is rare, albeit the most common primary intraocular malignancy among children. To elucidate the true incidence, trend and survival, we studied incidences and trends of retinoblastoma in a large population with long-term follow-up using data from 3 population-based cancer registries. Objective: To describe the incidence, trends and survival of RB between 1990 and 2009 in Khon Kaen, Songkhla and Chiang Mai, Thailand. Materials and Methods: We sourced the data from the cancer registries in Khon Kaen, Songkhla and Chiang Mai on children with retinoblastoma, diagnosed between 1990 and 2009. Retinoblastoma was defined as per the International Classification of Disease for Oncology version 3 using the code 9510/3. Incidence was analyzed using the standard method with the criteria of the International Association of Cancer Registries. The Kaplan-Meier method was applied to calculate cumulative survival. Trends were calculated using the log rank test. Results: We identified 75 cases of children between 0 and 15 years of age diagnosed with RB (Khon Kaen 31, Chiang Mai 20, Songkhla 24). Males and females were equally affected. The most common age group was 0-4 years. The morphological verification of the disease was 90.7%. The respective ASR in Khon Kaen, Chiang Mai and Songkhla was 4.4, 4.0 and 4.6 per million; for which the overall ASR for all 3 areas was 4.3 per million. The respective trend in incidence was 4, 2.8, 5.8 and 5.4 during 1990-4, 1995-9, 2000-4 and 2005-9. Overall, incidence trended gradually upward by 2% annually. The respective survival rate in Khon Kaen, Chiang Mai and Songkhla was 50, 40 and 75% (differences not significantly different at p
 Keywords
Retinoblastoma;incidence;trend;survival;Thailand;
 Language
English
 Cited by
 References
1.
Augsburger JJ (2009). Retinoblastoma. In: Yanoff and Duker. Ophthalmology. 3rd ed. Missouri: Mosby, 887-94.

2.
Broaddus E, Topham A, Singh DA (2009). Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol, 93, 21-23. crossref(new window)

3.
Broaddus E, Topham A, Singh DA (2009). Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol, 93, 24-27. crossref(new window)

4.
Chen YH, Lin YH, Hsu WM, Lee SM, Cheng CY (2010). Retinoblastoma in Taiwan: incidence and survival characteristics from 1979 to 2003. Eye (Lond), 24, 318-22. crossref(new window)

5.
Friedman DL (2011). Retinoblastoma. In: Lanzkowsky P. Manual of pediatric hematology and oncology. 5th ed. Amsterdam: Academic Pr, 759-75.

6.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, Whelan S (2000). International Classification of Disease for Oncology, 3rd edition. World Health Organization, Geneva.

7.
Kaufman PL, Paysse EA (2014). Overview of retinoblastoma [Internet]. [cited 2014 Jul 18]; Available from: http://goo.gl/kt2B9X

8.
MacCarthy A, Birch JM, Draper GJ, et al (2009). Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol, 93, 33-37. crossref(new window)

9.
MacCarthy A, Drapera GJ, Steliarova-Foucher E, Kingstone JE (2006). Retinoblastoma incidence and survival in European children (1978-1997). Report from the automated childhood cancer information system project. Eur J Cancer, 42, 2092-102. crossref(new window)

10.
Naseripour M, Falavarjani GK, Bakhtiari P, Vosough P, Aryan F (2009). Retinoblastoma survival in Iran: 10-year experiences of a referral center. Iranian J Ophthalmol, 21, 17-24.

11.
Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M (2009). Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol, 93, 28-32. crossref(new window)

12.
National Statistic Office (2003). Statistical data bank and information dissemination division. The 2000 population and housing census. Office of prime minister.

13.
Parkin DM, Kramarova E, Draper GL, et al (1998). International incidence of childhood cancer, Vol II. IARC scientific publication, 144.

14.
Ries LG, Smith MA, Gurney, et al (1999). Cancer incidence and survival among children and adolescent: United States SEER Program 1975-1995. NIH. Pub. No. 99-4649: Bethesda.

15.
Seregard S, Lundell G, Svedberg H, Kivela T (2004). Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Am Acad Ophthalmol, 111, 1228-32.

16.
Tamboli A, Podgor MJ, Horm JW (1990). The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol, 108, 128-32. crossref(new window)

17.
Tangcharoensathien V, Swasdiworn W, Jongudomsuk P, et al (2010). Universal coverage scheme in Thailand: equity outcomes and future agendas to meet challenges. Background paper, 43; World health report, World Health Organization.

18.
Saw SM, Tan N, Lee SB, Au Eong KG, Chia KS (2000). Incidence and survival characteristics of retinoblastoma in Singapore from 1968-1995. J Pediatr Ophthalmol Strabismus, 37, 87-93.

19.
Stiller CA (2004). Epidemiology and genetics of childhood cancer. Oncogene, 23, 6429-44. crossref(new window)

20.
Wiangnon S, Veerakul G, Nuchprayoon I, et al. (2011). Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai pediatric oncology group. Asian Pac J Cancer Prev, 12, 2215-20.

21.
Young JL, Smith MA, Rofferes SD, et al (1999). Retinoblastoma. In: Ries LAG, Smith MA, Gurney JG, Tamra T. Young JL, Bunin GR, editors. Cancer incidence and survival among children and adolescents: Unites States SEER Program 1975-1995. NIH Pub. No. 99-4649; 73-8.